Skip to main content

Table 3 Univariate analysis of predictors for overall survival. (n = 38)

From: Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Variables

Overall Survival Median

p-Value

Age

  ≤ 50

16.7

0.478

 >50

13.8

Gender

 Male

12.1

0.120

 Female

17.5

Treatment

 Conversion therapy

21.1

0.002

 Palliative chemotherapy

10.8

Tumor location

 Upper

11.3

0.343

 Middle and lower

15.7

Differentiation

 Poorly

11.6

0.087

 Moderately and well

18.1

Ascites

 Positive

15.3

0.774

 Negative

14.5

Initial DSL

 PCI<10

16.6

0.391

 PCI ≥ 10

13.2

Second DSL

 PCI<6

20.1

0.006

 PCI ≥ 6

11.3

Serum CEA (ng/ml)

 Normal

15.6

0.373

 >5

12.0

Serum CA19–9 (U/ml)

 Normal

15.9

0.359

 >39

12.1

Serum CA125 (U/ml)

 Normal

10.4

0.076

 >35

17.6

  1. DSL diagnostic staging laparoscopy, PCI peritoneal carcinomatosis index
  2. CEA carcinoembryonic antigen